These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8127033)

  • 41. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
    [No Abstract]   [Full Text] [Related]  

  • 42. WOFIE hypothesis: some thoughts on an approach toward allograft tolerance.
    Calne R
    Transplant Proc; 1996 Jun; 28(3):1152. PubMed ID: 8658605
    [No Abstract]   [Full Text] [Related]  

  • 43. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The common gammac-cytokines and transplantation tolerance.
    Li X
    Cell Mol Immunol; 2004 Jun; 1(3):167-72. PubMed ID: 16219163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transplantation for the millennium: attaining tolerance in our time--the Holy Grail.
    Helderman JH; Goral S
    Semin Nephrol; 2000 Jan; 20(1):83-6. PubMed ID: 10651221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of tolerance to alloantigen.
    Witzke O; Barbara JA; Wood KJ
    Rev Immunogenet; 1999; 1(3):374-86. PubMed ID: 11256428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The common gammac-cytokines and transplantation tolerance.
    Vu MD; Li XC
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):267-73. PubMed ID: 15467491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skin tolerance: in search of the Holy Grail.
    Horner BM; Randolph MA; Huang CA; Butler PE
    Transpl Int; 2008 Feb; 21(2):101-12. PubMed ID: 17903184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Perspectives of immunosuppressive therapy].
    Meuer S; Sido B; Dengler T
    Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From current immunosuppressive strategies to clinical tolerance of allografts.
    Golshayan D; Buhler L; Lechler RI; Pascual M
    Transpl Int; 2007 Jan; 20(1):12-24. PubMed ID: 17181648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In pursuit of the "holy grail": allograft tolerance.
    Nickerson PW; Steurer W; Steiger J; Strom TB
    Kidney Int Suppl; 1994 Jan; 44():S40-9. PubMed ID: 8127033
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.